[1]
Shreya Bhandari and Hasmitha Kamineni, “Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 receptors in Breast Cancer Patients”, Int. j. res. appl. sci. biotechnol., vol. 8, no. 4, pp. 104–109, Jul. 2021.